These data indicate that pterostilbene and allopurinol may reduce TGF-β1-mediated CTGF to suppress ANP, α-SMA, and FSP-1 overexpression in fructose-induced myocardial hypertrophy and fibrosis. Here, ATL1 is linked to cardiac hypertrophy.